KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $881,960 | +80.2% | 34,641 | -1.6% | 0.17% | +61.9% |
| Q3 2023 | $489,433 | -32.2% | 35,211 | +12.2% | 0.10% | -27.1% |
| Q2 2023 | $721,357 | +115.1% | 31,377 | +177.2% | 0.14% | +48.5% |
| Q1 2023 | $335,352 | +15.1% | 11,318 | -3.1% | 0.10% | -65.7% |
| Q4 2022 | $291,483 | +12.1% | 11,678 | -2.1% | 0.28% | +18.4% |
| Q3 2022 | $260,000 | +7.9% | 11,925 | -2.8% | 0.24% | +30.6% |
| Q2 2022 | $241,000 | -59.3% | 12,265 | -12.4% | 0.18% | -34.4% |
| Q1 2022 | $592,000 | -44.7% | 13,995 | -16.9% | 0.28% | -28.5% |
| Q4 2021 | $1,070,000 | – | 16,851 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |